10-Q Filing

ACUTUS MEDICAL, INC. CIK: 1522860 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001628280-21-016866`
Period End Date	20210630
Filing Date	20210813
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	afib-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 84 Cash Flow Statement 86 Stockholders Equity 34

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.13M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.23M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities, short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$73.89M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities, short-term	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$105.84M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.36M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.16M	USD	Point-in-time
Inventory	`InventoryNet`	$12.96M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.99M	shares	Point-in-time
Inventory	`InventoryNet`	$14.66M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	28.21M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.86M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	28.21M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$102.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$151.39M	USD	Point-in-time
Marketable securities, long-term	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$8.73M	USD	Point-in-time
Marketable securities, long-term	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$15.34M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$4.84M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$1.67M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.33M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.65M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.01M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$717.00K	USD	Point-in-time
Total assets	`Assets`	$140.59M	USD	Point-in-time
Total assets	`Assets`	$192.53M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.27M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$8.91M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.31M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$2.70M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$5.40M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$933.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$454.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.86M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$4.80M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.13M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.68M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.01M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.90M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$2.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$64.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$65.95M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of June 30, 2021 and December 31, 2020; no shares issued and outstanding as of June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of June 30, 2021 and December 31, 2020; no shares issued and outstanding as of June 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 28,211,626 and 27,991,425 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 28,211,626 and 27,991,425 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$487.29M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$494.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-418.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.01M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$280.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$156.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$140.59M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$192.53M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.30M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.13M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.72M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.71M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$14.45M	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$2.66M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.49M	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$5.86M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$8.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$18.54M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$16.15M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$9.17M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$31.85M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.12M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$15.60M	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.41M	USD	2 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-1.58M	USD	2 Qtrs
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$635.00K	USD	1 Quarter
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$-258.00K	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$63.43M	USD	2 Qtrs
Total costs and operating expenses	`OperatingCostsAndExpenses`	$32.01M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$20.60M	USD	1 Quarter
Total costs and operating expenses	`OperatingCostsAndExpenses`	$39.78M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-19.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.06M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-55.13M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-27.30M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$1.87M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.45M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$69.00K	USD	2 Qtrs
Interest income	`InterestAndOtherIncome`	$29.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$95.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$370.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.72M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.46M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.37M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.84M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-3.73M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-2.77M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-1.43M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-4.23M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-41.29M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.73M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.19M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-57.91M	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-57.91M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-28.73M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-14.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$10.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$4.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-41.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-134.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$96.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$92.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-41.26M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-58.03M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.63M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-23.11M	USD	1 Quarter
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-58.16	USD	2 Qtrs
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.02	USD	1 Quarter
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-2.06	USD	2 Qtrs
Net loss per common share, basic (in dollars per share)	`EarningsPerShareBasic`	$-32.24	USD	1 Quarter
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-58.16	USD	2 Qtrs
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.02	USD	1 Quarter
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-32.24	USD	1 Quarter
Net loss per common share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.06	USD	2 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	28.15M	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	719,421.00	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	709,961.00	shares	2 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	28.09M	shares	2 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	719,421.00	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.15M	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	709,961.00	shares	2 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.09M	shares	2 Qtrs

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-57.91M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-41.29M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$2.75M	USD	2 Qtrs
Depreciation expense	`Depreciation`	$600.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.50M	USD	1 Quarter
Depreciation expense	`Depreciation`	$978.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$100.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$220.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$320.00K	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$2.90M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$6.69M	USD	2 Qtrs
Amortization of premiums on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-5.00K	USD	2 Qtrs
Amortization of premiums on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-797.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$314.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$672.00K	USD	2 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$336.00K	USD	2 Qtrs
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$343.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$1.87M	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$2.45M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.41M	USD	2 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-1.58M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.20M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$597.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.62M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.71M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.50M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-666.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$289.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.73M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$5.29M	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$155.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.60M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-411.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-342.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-49.91M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-34.76M	USD	2 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	-	USD	2 Qtrs
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$9.13M	USD	2 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	2 Qtrs
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$4.59M	USD	2 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$44.41M	USD	2 Qtrs
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$40.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.84M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.45M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$52.65M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$34.02M	USD	2 Qtrs
Payment of deferred offering costs	`PaymentsOfFinancingCosts`	$10.00K	USD	2 Qtrs
Payment of deferred offering costs	`PaymentsOfFinancingCosts`	$701.00K	USD	2 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.62M	USD	2 Qtrs
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.76M	USD	2 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$619.00K	USD	2 Qtrs
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$205.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.12M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.15M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.00K	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-65.00K	USD	2 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$14.84M	USD	2 Qtrs
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-18.11M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.45M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.28M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.45M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	$38.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$2.38M	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$2.26M	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	-	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	-	USD	2 Qtrs
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	2 Qtrs
Change in unrealized (gain) loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$-41.00K	USD	2 Qtrs
Change in unrealized (gain) loss on marketable securities	`DebtSecuritiesUnrealizedGainLoss`	$10.00K	USD	2 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Right-of-use assets exchanged for operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$3.53M	USD	2 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$58.00K	USD	2 Qtrs
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$55.00K	USD	2 Qtrs
Unpaid deferred offering costs	`FinancingCostsIncurredButNotYetPaid`	$1.80M	USD	2 Qtrs
Unpaid deferred offering costs	`FinancingCostsIncurredButNotYetPaid`	$313.00K	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-14.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$10.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$4.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-41.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-134.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$96.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$69.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$92.00K	USD	1 Quarter
Stock option exercises (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	98,969.00	shares	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$450.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$619.00K	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$205.00K	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$205.00K	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$6.69M	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$3.78M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.90M	USD	2 Qtrs
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$1.16M	USD	1 Quarter
Issuance of common stock for cashless warrant exercise (in shares)	`StockIssuedDuringPeriodSharesCashlessWarrantsExercised`	26,958.00	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-23.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.29M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-57.91M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-28.73M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-263.97M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-242.22M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.86M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$100.26M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.